Anesthetic experiences in recurrent electroconvulsive therapy applications in geriatric patients

Declarations

References

1. Durmaz B, Soysal P, Ellidokuz H, Isik AT. Validity and reliability of Geriatric Depression Scale-15 (short form) in Turkish older adults. North Clin Istanb. 2018;5(3):216-220. doi:10.14744/nci.2017.85047
   Article · PubMed · Google Scholar
2. Heijnen WT, Birkenhäger TK, Wierdsma AI, van den Broek WW. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30(5):616-619. doi:10.1097/jcp.0b013e3181ee0f5f
   Article · PubMed · Google Scholar
3. Wagner KJ, Möllenberg O, Rentrop M, Werner C, Kochs EF. Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs. 2005;19(9):745-758. doi:10.2165/00023210-200519090-00002
   Article · PubMed · Google Scholar
4. Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: an overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61(5):373-380. doi:10.4103/ija.ija_132_17
   Article · PubMed · Google Scholar
5. Oflezer C, Atay Ö, Kaşdoğan ZE, Özakay G, İpekçioğlu D, Bahadır H. Does the use of rocuronium-sugammadex instead of succinylcholine in electroconvulsive therapy affect seizure duration? Psychiatry Investig. 2022;19(10):824-831.
   PubMed · Google Scholar
6. Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100(5):494-498. doi:10.1097/smj.0b013e318038fce0
   Article · PubMed · Google Scholar
7. Li H, Hou L, Wang D, et al. Response rate and safety of antidepressants combined with electroconvulsive therapy in adolescent depression: real-world clinical application. J Affect Disord. 2023;339:98-103. doi:10.1016/j.jad.2023.06.052
   Article · PubMed · Google Scholar
8. Kellner CH, Husain MM, Knapp RG, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE Study. Am J Psychiatry. 2016;173(11):1110-1118. doi:10.1176/appi.ajp.2016.16010118
   Article · PubMed · Google Scholar
9. Sackeim HA. Electroconvulsive therapy in late-life depression. In: Roose SP, Sackeim HA, eds. Late-Life Depression. Oxford University Press; 2004:241-278. doi:10.1093/oso/9780195152746.003.0021
   Article · PubMed · Google Scholar
10. Kaliora SC, Zervas IM, Papadimitriou GN. Electroconvulsive therapy: 80 years of use in psychiatry. Psychiatriki. 2018;29(4):291-302.
    PubMed · Google Scholar
11. Weiner RD, Reti IM. Key updates in the clinical application of electroconvulsive therapy. Int Rev Psychiatry. 2017;29(2):54-62. doi:10.1080/09540261.2017.1309362
    Article · PubMed · Google Scholar
12. Türkkal DC, Gökmen N, Yıldız A, et al. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine. J Clin Anesth. 2008;20(8):589-593.
    PubMed · Google Scholar
13. Nishiyama M, Togashi H. Effects of anesthetic agents on seizure duration and hemodynamics in electroconvulsive therapy. Masui. 2009;58(10):1266-1269.
    PubMed · Google Scholar
14. Köksal E, Üstün YB, Kaya C, Sahin AR, Sahinoglu AH. Elektrokonvülzif tedavide rokuronyum-sugammadeks ve süksinilkolinin derlenme üzerine etkilerinin karşılaştırılması [Comparing the effects of rocuronium-sugammadex and succinylcholine on recovery during electroconvulsive therapy]. Anadolu Psikiyatri Derg. 2015;16(3):198-204.
    PubMed · Google Scholar
15. Mirzakhani H, Guchelaar HJ, Welch CA, et al. Minimum effective doses of succinylcholine and rocuronium during electroconvulsive therapy: a prospective, randomized, crossover trial. Anesth Analg. 2016;123(3):587-596. doi:10.1213/ane.0000000000001218
    Article · PubMed · Google Scholar
16. Yalcin S, Aydogan H, Serdaroglu H. Rocuronium-sugammadex as an alternative to succinylcholine in electroconvulsive therapy. J Anesth. 2011;25(4):631; author reply 632. doi:10.1007/s00540-011-1164-x
    Article · PubMed · Google Scholar
17. Kramer BA, Kadar AG, Clark K. Use of the Neuro-Wrap system for severe post-electroconvulsive therapy headaches. J ECT. 2008;24(2):152-155. doi:10.1097/yct.0b013e318158e96f
    Article · PubMed · Google Scholar
18. Oflezer C, Atay Ö, Kaşdoğan ZE, Özakay G, İpekçioğlu D, Bahadır H. Does the use of rocuronium-sugammadex instead of succinylcholine in electroconvulsive therapy affect seizure duration? Psychiatry Investig. 2022;19(10):824-831.
    PubMed · Google Scholar
19. Takazawa T, Suto T, Aihara M, et al. Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency. JA Clin Rep. 2015;1(1):7. doi:10.1186/s40981-015-0009-2
    Article · PubMed · Google Scholar
20. Sagir O, Yucesoy Noyan F, Koroglu A, Cicek M, Ilksen Toprak H. Comparison between the effects of rocuronium, vecuronium, and cisatracurium using train-of-four and clinical tests in elderly patients. Anesth Pain Med. 2013;2(4):142-148.
    PubMed · Google Scholar
21. Kadoi Y, Hoshi H, Nishida A, Saito S. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy. J Anesth. 2011;25(6):855-859. doi:10.1007/s00540-011-1236-y
    Article · PubMed · Google Scholar
22. Ertan T, Eker E, Şar V. Geriatrik depresyon ölçeğinin Türk yaşlı nüfusunda geçerlilik ve güvenilirliği [Validity and reliability of the Geriatric Depression Scale in Turkish elderly population]. Noro Psikiyatr Ars. 1997;34(1):62-71.
    PubMed · Google Scholar
23. Şahin S, Aybastı Ö. Major depresyonda elektrokonvulsif terapinin oksidatif metabolizma üzerine etkisi [Effect of electroconvulsive therapy on oxidative metabolism in major depressive disorder]. Cukurova Med J. 2017;42(3):513-517. doi:10.17826/cutf.323838
    Article · PubMed · Google Scholar

Tables

Table 1. Measures of ECT stimulus dose, EEG seizure duration, motor seizure duration, hospitalization, orientation, and postoperative recovery time of the groups

Fullscreen

Table 2. Side effects of the groups

Fullscreen

Group S: ECT using succinylcholine as a neuromuscular blocker, Group R: ECT using rocuronium as a neuromuscular blocker, ECT: Electroconvulsive therapy *: p

Table 3. Geriatric depression score before ECT and after ECT of the groups

Fullscreen

Group S: ECT using succinylcholine as a neuromuscular blocker, Group R: ECT using rocuronium as a neuromuscular blocker, ECT: Electroconvulsive therapy *: p< 0.05. SS: Standard deviation, Min: Minimum, Max: Maximum.